Development, Recent Achievements and Current Directions of Research into GABA Uptake Inhibitors

Author(s): Paula Zaręba, Beata Gryzło, Gabriela Mazur, Barbara Malawska*

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 4 , 2021

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Neurotransmitter γ-aminobutyric acid (GABA) plays a principal role in the regulation of mammalian central nervous system functions. GABA evoked neurotransmission is terminated by a rapid uptake via dependent plasma membrane GABA transporters (GATs) located in the cell membrane. Potent inhibitors of these GATs are of fundamental importance for elucidation of the physiological function of these targets. Over recent years, a wide range of new GAT1-selective and less common non-GAT1-selective inhibitors have been successfully developed. This review highlights development and recent significant achievements in the field of GABA reuptake inhibitors. Special attention is paid to their pharmacological roles, structure and subtype selectivity relationships.

Keywords: GABA transporters, GAT1, BGT1, GAT2, GAT3, GABA uptake inhibitors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 10 October, 2019
Page: [750 - 776]
Pages: 27
DOI: 10.2174/0929867325666191010120236
Price: $65

Article Metrics

PDF: 141